Skip to content

Public FDA record

Z-1346-2022: CoolMax ZELTIQ Vacuum Applicator REF BRZ-AP1-080-000

Recall record Z-1346-2022 for Zeltiq Aesthetics, Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1346-2022
Company in FDA record
Zeltiq Aesthetics, Inc
FDA record creation date
Jul 11, 2022
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Executing a voluntary discontinuation and removal of parallel plate applicators due to an increase complaint rate for adverse event Paradoxical Hyperplasia (HP) during the 2019 to 2021 timeframe.

Source facts

Action
On 06/09/2022, the Recalling firm started sending an "URGENT: MEDICAL DEVICE RECALL" Letter via FedEx Overnight service to customers informing them discontinue and return all CoolSculpting Parallel Plate Applicators (CoolCore, CoolCurve, CoolCurve+, CoolMax, and CoolFit) due to an increase in the rate of complaints for Paradoxical hyperplasia (PH) (also referred to as Paradoxical Adipose Hyperplasia-PAH) during 2019 to 2021 timeframe. Customers are instructed to: 1. If you have the affected applicators, discontinue further use and quarantine products prior to return. 2. Monitor patients that have undergone a procedure per your normal clinical practice. . 3. Conduct a physical count of the affected applicators in your possession and record the count on the enclosed Business Response Form. 4. Send the Business Response Form to Qualanex, LLC. via fax or email within five business days of receipt. To ensure we are able to account for all recalled product, it is imperative that you return the form. Please return the Business Response Form even if no recalled product is present. 5. When returning the recalled products, attach the prepaid FedEx Authorized Return shipping label to the outside of the return carton and return the recalled product to: Qualanex, LLC. 1410 Harris Road Libertyville, IL 60048 5. Please do not return any products that are not the subject of this recall to this address. For questions or assistance, contact: Product Returns Contact Qualanex, LLC 1-800-505-9291, 7:00am - 4:00pm CST or recall@qualanex.com Adverse Events/Product Complaints Contact ZELTIQ at: 1-800-624-4261, 8am 5pm CST Medical Information Contact ZELTIQ at: 1-800-678-1605 option #2, 8:30 am 5:00 pm EST or IR-Medcom@allergan.com For after hours assistance, please leave a voicemail or email. A response will be provided within 48 hours.
Initiated
2022-06-09
Root cause
Unknown/Undetermined by firm
Distribution
U.S. AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, and WY. O.U.S.: United Arab Emirates, Argentina, Austria, Australia, Belgium, Bahrain, Bolivia, Canada, Switzerland, China, Cyprus, Czechia, Germany, Denmark, Spain, Finland, France, United Kingdom, Greece, Guatemala, Hong Kong, Indonesia, Ireland, Israel, India, Italy, Jordan, Japan, The Republic of Korea, Kuwait, Lebanon, Luxembourg, Latvia, Mexico, The Netherlands, Norway, Panama, Peru, Philippines, Poland, Portugal, Qatar, Russian Federation, Saudi Arabia, Sweden, Singapore, Thailand, Turkey, Taiwan, Uruguay, Venezuela, and South Africa.
Recall number
Z-1346-2022
Recall status
Open, Classified
CDRH record ID
194146
FDA record created
2022-07-11
Recall event number
90331

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗